Antihypertensive drugs and central blood pressure

Current Hypertension Reports

Volumn 11, Issue 4, 2009, Pages 253-259

  McEniery, Carmel M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CELIPROLOL; DILEVALOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; GLYCERYL TRINITRATE; INDAPAMIDE PLUS PERINDOPRIL; ISOSORBIDE MONONITRATE; LISINOPRIL; NEBIVOLOL; NITRATE; PERINDOPRIL; PLACEBO; SILDENAFIL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; DRUG CHOICE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MONOTHERAPY; REVIEW; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; AORTA; DIASTOLE; DRUG EFFECT; SYSTOLE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; DIASTOLE; DIURETICS; HUMANS; HYPERTENSION; RECEPTOR, ANGIOTENSIN, TYPE 2; SYSTOLE; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS;

EID: 67651119713     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0043-4     Document Type: Review

References (49)

1. Remington JW, Wood EH: Formation of the peripheral pulse contour in man. J Applied Physiol 1956, 9: 433-442.
2. Kroeker EJ, Wood EH: Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man. Circ Res 1955, 3: 623-632.
3. McEniery CM, Yasmin, McDonnell B, et al.; on behalf of the Anglo-Cardiff CollaborativV Trial Investigators: Central pressure: variability and impact of cardiovascular risk factors: The Anglo-Cardiff Collaborative Trial II. Hypertension 2008, 51: 1476-1482.
4. Camacho F, Avolio A, Lovell NH: Estimation of pressure pulse amplification between aorta and brachial artery using stepwise multiple regression models. Physiol Meas 2004, 25: 879-889.
5. Pauca AL, O'Rourke MF, Kon ND: Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001, 38: 932-937.
6. Pauca AL, Kon ND, O'Rourke MF: The second peak of the radial artery pressure wave represents aortic systolic pressure in hypertensive and elderly patients. Br J Anaesth 2004, 92: 651-657.
7. Takazawa K, Kobayashi H, Shindo N, et al.: Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res 2007, 30: 219-228.
8. Waddell TK, Dart AM, Medley TL, et al.: Carotid pressure is a better predictor of coronary artery disease severity than brachial pressure. Hypertension 2001, 38: 927-931.
9. Philippe F, Chemaly E, Blacher J, et al.: Aortic pulse pressure and extent of coronary artery disease in percutaneous transluminal coronary angioplasty candidates. Am J Hypertens 2002, 15: 672-677.
10. Lu TM, Hsu NW, Chen YH, et al.: Pulsatility of ascending aorta and restenosis after coronary angioplasty in patients >60 years of age with stable angina pectoris. Am J Cardiol 2001, 88: 964-968.
11. Nakayama Y, Tsumura K, Yamashita N, et al.: Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty. Circulation 2000, 101: 470-472.
12. Saba PS, Roman MJ, Pini R, et al.: Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993, 22: 1873-1880.
13. Boutouyrie P, Bussy C, Lacolley P, et al.: Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999, 100: 1387-1393.
14. Tanaka H, Dinenno FA, Monahan KD, et al.: Carotid artery wall hypertrophy with age is related to local systolic blood pressure in healthy men. Arterioscler Thromb Vasc Biol 2001, 21: 82-87.
15. Levy D, Garrison R, Savage DD, et al.: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990, 332: 1561-1566.
16. Simons PCG, Algra A, Bots ML, et al.: Common carotid intima-media thickness and arterial stiffness: Indicators of cardiovascular risk in high-risk patients: The SMART study (Second Manifestations of ARTerial disease). Circulation 1999, 100: 951-957.
17. Safar ME, Blacher J, Pannier B, et al.: Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002, 39: 735-738.
18. Roman MJ, Devereux RB, Kizer JR, et al.: Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension 2007, 50: 197-203.
19. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288: 2981-2997.
20. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001, 358: 1305-1315.
21. Carlberg B, Samuelsson O, Lindholm LH: Atenolol in hypertension: Is it a wise choice? Lancet 2004, 364: 1684-1689.
22. Lindholm LH, Carlberg B, Samuelsson O: Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005, 366: 1545-1553.
23. Medical Research Council trial of treatment of hypertension in older adults: Principal results. MRC Working Party. BMJ 1992, 304: 405-412.
24. Dahlöf B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002, 359: 995-1003.
25. Dahlöf B, Sever PS, Poulter NR, et al.: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005, 366: 895-906.
26. Asmar RG, London GM, O'Rourke ME, Safar ME: Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol. Hypertension 2001, 38: 922-926.
27. Williams B, Lacy PS, Thom SM, et al.: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113: 1213-1225.
28. Deary AJ, Schumann AL, Murfet H, et al.: Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci 2002, 103: 493-499.
29. Morgan T, Lauri J, Bertram D, Anderson A: Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004, 17: 118-123.
30. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF: Benefits from angiotensin-converting enzyme inhibitor "beyond blood pressure lowering": Beyond blood pressure or beyond the brachial artery? J Hypertens 2005, 23: 551-556.
31. Dhakam Z, McEniery CM, Yasmin, et al.: Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006, 19: 214-219.
32. Dhakam Z, Yasmin, McEniery CM, et al.: A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 2008, 26: 351-356.
33. London GM, Pannier B, Guerin AP, et al.: Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994, 90: 2786-2796.
34. London GM, Pannier B, Vicaut E, et al.: Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition. J Hypertens 1996, 14: 1139-1146.
35. Mitchell GF, Izzo JL Jr, Lacourciere Y, et al.: Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: Results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002, 105: 2955-2961.
36. Stokes GS, Barin ES, Gilfillan KL: Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension. Hypertension 2003, 41: 297-301.
37. Ahimastos AA, Natoli AK, Lawler A, et al.: Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension 2005, 45: 1194-1199.
38. Dart AM, Cameron JD, Gatzka CD, et al.: Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension 2007, 49: 1242-1247.
39. Aznaouridis KA, Stamatelopoulos KS, Karatzis EN, et al.: Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients. J Hum Hypertens 2007, 21: 654-663.
40. Jiang XJ, O'Rourke MF, Zhang YQ, et al.: Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens 2007, 25: 1095-1099.
41. Tropeano AI, Boutouyrie P, Pannier B, et al.: Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006, 48: 80-86.
42. Mahmud A, Feely J: Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension. J Hum Hypertens 2000, 14: 541-546.
43. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ: Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 2001, 37: 1429-1433.
44. Wilkinson IB, MacCallum H, Flint L, et al.: The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000, 525(Pt 1): 263-270.
45. Kelly R, Daley J, Avolio A, O'Rourke M: Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension. Hypertension 1989, 14: 14-21.
46. Boutouyrie P, Bussy C, Hayoz D, et al.: Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation 2000, 101: 2601-2606.
47. Kelly RP, Gibbs HH, O'Rourke MF, et al.: Nitroglycerine has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990, 11: 138-144.
48. Duchier J, Iannascoli F, Safar M: Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cardiol 1987, 60: 99-102.
49. Mancia G, De Backer G, Dominiczak A, et al.: 2007 ESH-ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007, 16: 135-232.